All In Biotech

Free tool

FAERS Monitor: Imodium A-D

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019860 or its brand name (Imodium A-D, Loperamide Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

44,941

Serious

27,585

61% of reports

Hospitalization

16,194

Death reported

3,911

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea8,976
  • nausea4,323
  • drug ineffective4,099
  • fatigue3,916
  • off label use3,251
  • vomiting2,788
  • constipation2,503
  • weight decreased2,103
  • headache2,046
  • dyspnoea2,020
  • decreased appetite1,843
  • asthenia1,839
  • abdominal pain1,818
  • dizziness1,733
  • pain1,651

Reports by year received

View as table
YearReports
2004355
2005383
2006393
2007439
2008529
2009595
2010639
2011654
20121,057
2013948
20141,140
20153,461
20162,284
20173,131
20183,200
20193,186
20203,123
20212,864
20223,372
20233,683
20243,569
20253,540
20262,393

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,009,218 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diarrhoeaSignal8,9766.66.543,254
constipationSignal2,5035.45.29,013
decreased appetiteSignal1,8433.73.63,700
abdominal painSignal1,8183.73.53,554
weight decreasedSignal2,1033.53.43,862
vomitingSignal2,7882.82.73,243
nauseaSignal4,3232.62.54,264
fatigueSignal3,9162.42.33,173
astheniaSignal1,8392.32.21,361
off label use3,2511.71.71,064
dyspnoea2,0201.71.6559
dizziness1,7331.61.6428
headache2,0461.51.5384
drug ineffective4,0991.51.4624
pain1,6511.31.290

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.